Menopause

被引:180
作者
Davis, Susan R. [1 ]
Lambrinoudaki, Irene [2 ,3 ]
Lumsden, Maryann [4 ]
Mishra, Gita D. [5 ]
Pal, Lubna [6 ]
Rees, Margaret [7 ]
Santoro, Nanette [8 ]
Simoncini, Tommaso [9 ]
机构
[1] Monash Univ, Sch Publ Hlth & Prevent Med, 99 Commercial Rd, Melbourne, Vic 3004, Australia
[2] Univ Athens, Med Sch, Athens, Greece
[3] Aretaieio Univ Hosp, Athens, Greece
[4] Glasgow Royal Infirm, Reprod & Maternal Med, Glasgow, Lanark, Scotland
[5] Univ Queensland, Fac Med & Biomed Sci, Sch Populat Hlth, Brisbane, Qld 4072, Australia
[6] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA
[7] John Radcliffe Hosp, Womens Ctr, Oxford, England
[8] Univ Colorado, Sch Med, Aurora, CO USA
[9] Univ Pisa, Pisa, Italy
来源
NATURE REVIEWS DISEASE PRIMERS | 2015年 / 1卷
关键词
QUALITY-OF-LIFE; ANTI-MULLERIAN HORMONE; VULVO-VAGINAL ATROPHY; ESTROGEN PLUS PROGESTIN; CORONARY-HEART-DISEASE; MIDDLE-AGED WOMEN; BODY-MASS INDEX; POSTMENOPAUSAL WOMEN; VASOMOTOR SYMPTOMS; NATURAL MENOPAUSE;
D O I
10.1038/nrdp.2015.4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Menopause is an inevitable component of ageing and encompasses the loss of ovarian reproductive function, either occurring spontaneously or secondary to other conditions. It is not yet possible to accurately predict the onset of menopause, especially early menopause, to give women improved control of their fertility. The decline in ovarian oestrogen production at menopause can cause physical symptoms that may be debilitating, including hot flushes and night sweats, urogenital atrophy, sexual dysfunction, mood changes, bone loss, and metabolic changes that predispose to cardiovascular disease and diabetes. The individual experience of the menopause transition varies widely. Important influential factors include the age at which menopause occurs, personal health and wellbeing, and each woman's environment and culture. Management options range from lifestyle assessment and intervention through to hormonal and non-hormonal pharmacotherapy, each of which has specific benefits and risks. Decisions about therapy for perimenopausal and postmenopausal women depend on symptomatology, health status, immediate and long-term health risks, personal life expectations, and the availability and cost of therapies. More effective and safe therapies for the management of menopausal symptoms need to be developed, particularly for women who have absolute contraindications to hormone therapy. For an illustrated summary of this Primer, visit: http://go.nature.com/BjvJVX
引用
收藏
页数:19
相关论文
共 215 条
  • [1] Cardiovascular Risk in Women: Focus on Hypertension
    Abramson, Beth L.
    Melvin, Rochelle G.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (05) : 553 - 559
  • [2] The effects of body mass index on age at menopause
    Akahoshi, M
    Soda, M
    Nakashima, E
    Tominaga, T
    Ichimaru, S
    Seto, S
    Yano, K
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (07) : 961 - 968
  • [3] Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial
    Al-Akoum, Mahera
    Maunsell, Elizabeth
    Verreault, Rene
    Provencher, Louise
    Otis, Helene
    Dodin, Sylvie
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (02): : 307 - 314
  • [4] Menopausal hormone therapy and menopausal symptoms
    Al-Safi, Zain A.
    Santoro, Nanette
    [J]. FERTILITY AND STERILITY, 2014, 101 (04) : 905 - 915
  • [5] Bone loss in young women with karyotypically normal spontaneous premature ovarian failure
    Anasti, JN
    Kalantaridou, SN
    Kimzey, LM
    Defensor, RA
    Nelson, LM
    [J]. OBSTETRICS AND GYNECOLOGY, 1998, 91 (01) : 12 - 15
  • [6] [Anonymous], 2013, Obstet Gynecol, V121, P887, DOI 10.1097/01.AOG.0000428645.90795.d9
  • [7] [Anonymous], COCHRANE DATABASE SY
  • [8] [Anonymous], HUM REPROD
  • [9] [Anonymous], MENOPAUSE POSTMENOPA
  • [10] [Anonymous], CLIMACTERIC